Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Theravance |
---|---|
Information provided by: | Theravance |
ClinicalTrials.gov Identifier: | NCT00391820 |
Study 0038 compares the safety and effectiveness of an investigational drug, TD-5108 with placebo (a sugar pill) for the treatment of chronic constipation.
Condition | Intervention | Phase |
---|---|---|
Chronic Constipation |
Drug: TD-5108 |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of TD-5108 for the Treatment of Chronic Constipation |
Ages Eligible for Study: | 18 Years to 64 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | 0038 |
Study First Received: | October 20, 2006 |
Last Updated: | May 16, 2007 |
ClinicalTrials.gov Identifier: | NCT00391820 |
Health Authority: | United States: Food and Drug Administration |
constipation chronic bowel function |
Signs and Symptoms Signs and Symptoms, Digestive Constipation Serotonin |